Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
196 Leser
Artikel bewerten:
(0)

BCM-95 (Curcugreen) Granted New Patent in Europe

KERALA, India, April 10, 2019 /PRNewswire/ -- Arjuna Natural Ltd. has been granted a new patent in Europe for its applied technology of improving the bioavailability of curcumin in its BCM-95(Curcugreen) formulation and a leading product in its broad portfolio of natural ingredients.

BCM-95 (Curcugreen) granted new patent in Europe

The new patent enables Arjuna to further expand its strong hold in 20 additional countries across Western and Eastern Europe. It is already a leading brand in the United States and is protected by 49 patents (14 in the US, 2 in Japan and 33 in European Countries) for composition and manufacturing processes of curcumin extract. The patented formulation provides biologically active curcumin with essential oil of turmeric. The 100% natural formulation is extensively backed by over 55 published studies worldwide and several on-going studies for its therapeutic activity on multiple health indications, making it unparalleled in the segment.

"The composition of BCM-95 (Curcugreen) contains only turmeric based components and no synthetic or non-turmeric ingredients," says Benny Antony, PhD, Joint Managing Director for Arjuna. "This composition of turmeric delivers free curcumin into blood and is retained in the body for longer duration," notes Antony.

This patent in effect helps to address much confusion in the market regarding curcumin absorption and oral bioavailability. The main problem of curcumin is that it is not absorbed nor retained well in the blood streams. Yet, the market has subsequently been flooded with curcumin products laden with synthetic additives in attempts to overcome the issue of bioavailability. Also it is observed that many brands are toll manufactured at production centers not complying to cGMP standards.

"Any supplement you put into your body should be both safe and effective," insists Antony. "Arjuna's BCM-95 (Curcugreen) is wholly manufactured in its own facility under a fully automated cGMP complied continuous extraction plant-using only solar power. This has enabled Arjuna to triple its manufacturing capacity in Coimbatore, India to meet the growing demand for their brand of curcumin in the coming years.

The success of BCM-95 (Curcugreen) has enabled Arjuna to rev up its marketing activities and cement its foothold in the European market as well as in the USA. "With the mobilization of our dedicated sales force we hope to increase our market reach significantly in the coming years." Says P.J Kunjachan, Chairman & Managing Director. BCM-95 (Curcugreen) enjoys GRAS status as a pure and trusted brand for use in medical foods following a comprehensive review by a panel of qualified experts.

About Arjuna Natural Ltd.

For more than a quarter of a century Arjuna Natural Ltd. has been India's leading manufacturer of standardized spice & botanical extracts for food supplement industries dedicated firmly to ecofriendly practices. Established in 1992, the company has grown rapidly, with customers in 50 countries. The advanced R&D unit is a complete research facility that works in collaboration with international universities on phytochemistry, pharmacokinetics, formulation, development, pre-clinical and toxicity studies

Visit us at Vitafoods, Geneva, May 7-9, booth C30

For further information, please contact:

Company contact

Benny Antony, PhD
Joint Managing Director
Email: benny@arjunanatural.com
Website: www.arjunanatural.com
Twitter: @ArjunaExtracts

Press Contact

NutriPR
Liat Simha
Tel: +972-9-9742893
E-mail: liat@nutripr.com
Website: www.nutripr.com
Twitter: @LiatSimha

Photo: https://mma.prnewswire.com/media/869578/Arjuna_Natural_BCM_95.jpg

© 2019 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.